“We are very impressed with Syngene’s professionalism, commitment to scientific excellence, and ability to deliver high-quality work on time,” said Allan Wehnert, CEO & Founder of Orocidin. “This ...

Sam Finn, a senior research associate at Zymo Research working with the Oncology Diagnostic Team, helped to host this interactive game booth at the “BioFestival” on Tuesday.

Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...

The new center at Bridge Labs will train the workforce powering North Texas’ biotech boom—helping startups speed therapies, ...

Cellevate AB, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing ...

The SNU BioTalk 2025 an International Conference, themed "Symphony of Cellular Signals in Metabolism and Immune Response," was a landmark event organized under the visionary leadership of Prof. (Dr).

HYDERABAD, IN / ACCESSWIRE / 17, 2025 / Foxx Life Sciences is delighted to announce the successful completion of its Open House event, held at the comp ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

CONTINUED... Read this and more news for Oncolytics Biotech at: In other recent industry developments and happenings in the m ...